Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
September 20 2022 - 3:40PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of September 2022
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Celyad Oncology SA
On September 20, 2022, Celyad Oncology SA (the Company) issued a press release announcing its entry into a transaction whereby
Cellistic will acquire the Companys Good Manufacturing Practice grade cell therapy manufacturing capability, including the existing facility and all related personnel. A copy of the Companys press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.
The information contained in this Current Report on Form 6-K,
including Exhibit 99.1, except for the quotes of Michel Lussier and Stefan Braam contained in Exhibit 99.1, is hereby incorporated by reference into the Companys Registration Statements on Forms F-3
(File No. 333-248464) and S-8 (File No. 333-220737).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA |
|
|
|
|
Date: September 20, 2022 |
|
|
|
By: |
|
/s/ Michel Lussier |
|
|
|
|
|
|
Michel Lussier |
|
|
|
|
|
|
Interim Chief Executive Officer |
Celyad (CE) (USOTC:CLYYF)
Historical Stock Chart
From Sep 2024 to Oct 2024
Celyad (CE) (USOTC:CLYYF)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Celyad SA (CE) (OTCMarkets): 0 recent articles
More Celyad Oncology Sa News Articles